Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10480031
Method for generating Retinal Pigment Epithelium (RPE) cells from Induced Pluripotent Stem Cells (IPSCs)
granted -
US 10479993
Modulation of signal transducer and activator of transcription 3 (STAT3) expression
granted -
US 10479980
Artificial ovary
granted -
US 10479868
Polymeric stabilizing formulations
granted -
US 10479839
Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
granted -
US 10479830
Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines
granted -
US 10479798
Six-membered ring benzo derivatives as DPP-4 inhibitor and use thereof
granted -
US 10479825
Antibody-mediated neutralization of Marburg virus
granted -
US 10478508
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
granted -
US 10478505
Edible oils to enhance delivery of orally administered steroids
granted -
US 10479783
Compositions and methods for inhibition of the JAK pathway
granted -
US 10478513
Nitroxide containing amyloid binding agents for imaging and therapeutic uses
granted -
US 10478500
Compositions and methods for inhibition of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) gene expression
granted -
US 10478485
Methods and compositions to prevent or treat bacterial infections
granted -
US 10479784
Substituted pyrazin-2-amines as inhibitors of ATR kinase
granted -
US 10478435
Use of CRAC channel inhibitors for the treatment of stroke and traumatic brain injury
granted -
US 10478461
Cellular extracts
granted -
CA 3094896
COMPOSES DE 1H-INDAZOLE-3-CARBOXAMIDE UTILISES EN TANT QU'INHIBITEURS DE LA GLYCOGENE SYNTHASE KINASE 3 BETA
granted -
US 10471061
Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders
granted -
US 10471142
Combination therapy using immunoglobulin and C1-Inhibitor
granted -
US 10472357
Triazolopyridine compounds and methods for the treatment of cystic fibrosis
granted -
US 10471014
Pharmaceutical compositions comprising meloxicam
granted -
US 10471144
Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer
granted -
US 10472363
SGC stimulators
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.